Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2003;108:192-197
Published online before print June 30, 2003, doi: 10.1161/01.CIR.0000080291.65638.CC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
108/2/192    most recent
01.CIR.0000080291.65638.CCv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Himmrich, E.
Right arrow Articles by Meyer, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Himmrich, E.
Right arrow Articles by Meyer, J.
Related Collections
Right arrow Pacemaker
Right arrow Ablation/ICD/surgery
Right arrow Arrhythmias, clinical electrophysiology, drugs

(Circulation. 2003;108:192.)
© 2003 American Heart Association, Inc.


Clinical Investigation and Reports

Proarrhythmic Effect of Pacemaker Stimulation in Patients With Implanted Cardioverter-Defibrillators

Ewald Himmrich, MD; Oliver Przibille, MD; Christian Zellerhoff, MD; Andreas Liebrich, MD; Stefan Rosocha, MD; Klaus Andreas, MD; Dirk Nebeling, RN; Babatunde Omogbehin, MD; Jürgen Meyer, MD

From II Medical Clinic, University Hospital, Mainz, Germany.

Correspondence to PD Dr med Ewald Himmrich, II. Medical Clinic, University Hospital, Langenbeckstraße 1, D-55131 Mainz, Germany. E-mail himmrich{at}2-med.klinik.uni-mainz.de

Background— We sought to determine the potential of right ventricular VVI backup pacing to induce ventricular tachyarrhythmias in patients with implanted cardioverter-defibrillators.

Methods and Results— All consecutive patients presenting exclusively with pacemaker-induced tachycardias (PITs) were included in a prospective study using a crossover protocol. Patients were randomized to either group 1 (augmentation of the baseline frequency of the pacemaker to 60 bpm) or group 2 (pacemaker turned off) and were followed up for 1 year and then crossed over to the other programming, looking for reoccurrence of PIT. Of 150 consecutive patients, 39 (26%) had PIT, 13 of them exclusively (8.6%). Forty of 1063 analyzed tachyarrhythmias of all the patients were PIT (3%). Before inclusion in the study, the patients had 2.7±0.9 PITs in 11±6.5 months with their pacemakers programmed empirically at 42.3 bpm. During the study phase, no PIT occurred while the pacemaker was turned off, whereas programming to 60 bpm led to the recurrence of PIT in 5 of 6 patients (1.4±0.6 per patient). At the end of the study, 9 patients underwent a prolonged follow-up with their pacemakers turned off, resulting in spontaneous episodes of ventricular tachycardia/fibrillation in 5 patients, but PITs were no longer observed.

Conclusions— This crossover protocol proves the potential proarrhythmic effect of pacemaker stimulation in implantable cardioverter-defibrillator patients. Resulting PITs led to clinical symptoms and antitachycardia therapy by the implantable cardioverter-defibrillator. Thus, in patients presenting with PIT but without a pacemaker indication, the pacemaker feature should be turned off, or, alternatively, the longest possible escape interval should be programmed.


Key Words: electrical stimulation • tachyarrhythmias • pacing • cardioverter-defibrillator




This article has been cited by other articles:


Home page
Circ Arrhythm ElectrophysiolHome page
J. Osorio, D. J. Dosdall, R. P. Robichaux Jr, P. B. Tabereaux, and R. E. Ideker
In a Swine Model, Chest Compressions Cause Ventricular Capture and, By Means of a Long-Short Sequence, Ventricular Fibrillation
Circ Arrhythm Electrophysiol, October 1, 2008; 1(4): 282 - 289.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. Tung, P. Zimetbaum, and M. E. Josephson
A Critical Appraisal of Implantable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death
J. Am. Coll. Cardiol., September 30, 2008; 52(14): 1111 - 1121.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Ghosh, E. K. Rhee, J. N. Avari, P. K. Woodard, and Y. Rudy
Cardiac Memory in Patients With Wolff-Parkinson-White Syndrome: Noninvasive Imaging of Activation and Repolarization Before and After Catheter Ablation
Circulation, August 26, 2008; 118(9): 907 - 915.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
A. Gardiwal, H. Yu, H. Oswald, U. Luesebrink, A. Ludwig, A. M. Pichlmaier, H. Drexler, and G. Klein
Right ventricular pacing is an independent predictor for ventricular tachycardia/ventricular fibrillation occurrence and heart failure events in patients with an implantable cardioverter-defibrillator
Europace, March 1, 2008; 10(3): 358 - 363.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. O. Sweeney, L. L. Ruetz, P. Belk, T. J. Mullen, J. W. Johnson, and T. Sheldon
Bradycardia Pacing-Induced Short-Long-Short Sequences at the Onset of Ventricular Tachyarrhythmias: A Possible Mechanism of Proarrhythmia?
J. Am. Coll. Cardiol., August 14, 2007; 50(7): 614 - 622.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
H. Nagele, S. Hashagen, M. Azizi, S. Behrens, and M.A. Castel
Analysis of terminal arrhythmias stored in the memory of pacemakers from patients dying suddenly
Europace, June 1, 2007; 9(6): 380 - 384.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. Arzt and T. D. Bradley
Treatment of Sleep Apnea in Heart Failure
Am. J. Respir. Crit. Care Med., June 15, 2006; 173(12): 1300 - 1308.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
M. Biffi, G. Boriani, M. Bertini, P. Silvestri, C. Martignani, and A. Branzi
Pacing with capture verification in candidates for resynchronisation therapy: A feasibility study
Europace, January 1, 2005; 7(3): 255 - 265.
[Abstract] [Full Text] [PDF]